The Pharmacy HCT Core Topics Connection Live Session will air on Thursday, January 9, at 2:00 – 3:00 pm CST. This live session will focus on two core topics in hematopoietic cell transplantation – HCT Complications and Infectious Diseases in HCT. The faculty below will answer questions about their respective topics and share their experiences from their institutions. The target audience is PGY2 Oncology Pharmacy Residents, but is open to all trainees practicing or interested in transplantation and

The webinar will focus on international survivorship guidelines surveillance recs on SMN screening- specifically breast and colorectal cancer and will provide more background and rationale for changes in the recommendations in new guidelines. Neel S. Bhatt, MBBS, MPH, Fred Hutchinson Cancer Center/ University of Washington Rachel Phelan, MD, MPH, Medical College of Wisconsin/Children’s Wisconsin Seth Rotz, MD, Cleveland Clinic Children’s

Learn about the new Mentorship program initiated by the ASTCT APP Special Interest Group. This session will air live on Wednesday, December 4, from 3-4 p.m. CST. Come and find an experienced Mentor that matches your needs or establish yourself as a Mentor to help others learn from your expertise. You can build new skills and impact your professional development by participating. Finally, if you just want to improve your skills in mentoring, we will provide tips and guidance. This will be an interactive

The webinar will focus on international survivorship guidelines surveillance recs on SMN screening- specifically breast and colorectal cancer and will provide more background and rationale for changes in the recommendations in new guidelines. Neel S. Bhatt, MBBS, MPH, Fred Hutchinson Cancer Center/ University of Washington Rachel Phelan, MD, MPH, Medical College of Wisconsin/Children’s Wisconsin Seth Rotz, MD, Cleveland Clinic Children’s

The webinar will focus on international survivorship guidelines surveillance recs on SMN screening- specifically breast and colorectal cancer and will provide more background and rationale for changes in the recommendations in new guidelines. Neel S. Bhatt, MBBS, MPH, Fred Hutchinson Cancer Center/ University of Washington Rachel Phelan, MD, MPH, Medical College of Wisconsin/Children’s Wisconsin Seth Rotz, MD, Cleveland Clinic Children’s

The ASTCT Pharmacy SIG November 2024 Journal Club will air on Wednesday, November 20, 2024 at 2 pm CST/3 pm EST. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. In this Journal Club session, Drs. Kasper and Atkins will present on two articles related to: (a) Axatilimab in recurrent or refractory cGvHD and (b) safety and efficacy of maribavir versus valganciclovir inpatients with CMV post-HCT.

The ASTCT Pharmacy SIG November 2024 Journal Club will air on Wednesday, November 20, 2024 at 2 pm CST/3 pm EST. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. In this Journal Club session, Drs. Kasper and Atkins will present on two articles related to: (a) Axatilimab in recurrent or refractory cGvHD and (b) safety and efficacy of maribavir versus valganciclovir inpatients with CMV post-HCT.

The ASTCT Pharmacy SIG November 2024 Journal Club will air on Wednesday, November 20, 2024 at 2 pm CST/3 pm EST. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. In this Journal Club session, Drs. Kasper and Atkins will present on two articles related to: (a) Axatilimab in recurrent or refractory cGvHD and (b) safety and efficacy of maribavir versus valganciclovir inpatients with CMV post-HCT.